October 05, 2021 06:38 AM Eastern Daylight Time
BUSINESS WIRE
Celltrion Healthcare presenta alla UEG Week Virtual 2021 dati positivi sullo switch terapeutico e sulla monoterapia con Remsima® SC nei pazienti affetti da malattie infiammatorie intestinali
Tweet
View Full Size
Download
Full Size
JPEG
,
2526
x
822
,
153.4 KB
Small
JPEG
,
480
x
156
,
24.8 KB
Preview
JPEG
,
144
x
47
,
5.3 KB
Thumbnail
JPEG
,
120
x
39
,
3.7 KB
Smart Multimedia Gallery
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Celltrion Healthcare presenta alla UEG Week Vir...